International Network of VENous Thromboembolism Clinical Research Networks

News

Site News
« Back to listings

This survey was reviewed and endorsed by INVENT Network leadership. Participation is voluntary and at your discretion. The message that follows is from the survey administrator; please correspond with them directly if you have any questions concerning the survey.



Dear researchers,

We are asking all thrombosis researchers to please complete our online Thrombosis and COVID-19 Research: Collaboration Survey so we can better understand current research efforts underway in thrombosis and COVID-19, and the level of collaboration happening to develop thrombosis research projects around the world. 

By completing this survey, you have the chance to win one of three Amazon gift cards each with the value of $100 CAD.

This study has been approved by the University of Calgary Conjoint Faculties Research Ethics Board (REB 19-1447). Some questions will ask you about the names of your collaborators for a social network analysis. This data is confidential and will be anonymized.

We appreciate your help during this very busy time. By understanding what thrombosis-related COVID-19 research is underway, we can better coordinate our efforts as a global thrombosis research community. 

Thrombosis and COVID-19 Research: Collaboration Survey 

Please feel free to contact Dr. Leslie Skeith (PI) at laskeith@ucalgary.ca or Alexandra Garven (research coordinator) at alexandra.garven@ucalgary.ca with any questions or comments about this study.

Thank you for considering!
 

Leslie Skeith, MD, FRCPC, MHPE
Assistant Professor, University of Calgary
Division of Hematology & Hematological Malignancies
Phone: 403-944-5246; Fax: 403-944-1647
Principal Investigator for the PARTUM Trial
Twitter @leslieskeith

Comments

There are currently no comments.

Log in to post a comment.

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.